🔎 Trials Near Me

Akèy › Artrit Rematoid › Massachusetts

Etid klinik pou Artrit Rematoid nan Massachusetts

8 etid pou Artrit Rematoid ap chèche patisipan nan sit nan Massachusetts.

Vil nan Massachusetts

Tèks ofisyèl etid la (Anglè)

RA-PRO PRAGMATIC TRIAL

  • Tufts University, Boston
  • University of Massachusetts Chan Medical School, Worcester
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT04692493

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  • Massachusetts General Hospital, Boston
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Aug 21, 2026 · NCT06570798

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Brigham And Womens Hospital, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07115745

The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study

  • Massachusetts General Hospital: Rheumatology, Boston
  • Brigham and Womens Hospital, Boston
  • Brigham and Women's Faulkner Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 35 a 79 · Tout sèks · Mizajou Jul 14, 2026 · NCT07315997

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

  • Tufts University, Boston
  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Jun 30, 2026 · NCT06201416

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

  • Research Site, New Bedford
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 24, 2026 · NCT07276581

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

  • Tufts University, Boston
  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 18 a 71 · Tout sèks · Mizajou Apr 16, 2026 · NCT07123038

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.